Brenda Libby Coleman

Array ( [id] => 6148681 [patent_doc_number] => 20110020276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Pyrrolidine Fused Indolobenzadiazepine HCV NS5B Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/922752 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13398 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020276.pdf [firstpage_image] =>[orig_patent_app_number] => 12922752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8177263 [patent_doc_number] => 08178523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Compounds for the treatment of hepatitis C' [patent_app_type] => utility [patent_app_number] => 12/922722 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15028 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178523.pdf [firstpage_image] =>[orig_patent_app_number] => 12922722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729699 [patent_doc_number] => 08101596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Loxapine analogs and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/411083 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53966 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101596.pdf [firstpage_image] =>[orig_patent_app_number] => 12411083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8784724 [patent_doc_number] => 08431568 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors' [patent_app_type] => utility [patent_app_number] => 12/922801 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9516 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12922801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125210 [patent_doc_number] => 20110085978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'NOVEL QUINOLINYLAMIDE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE AND SEROTONIN RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/922368 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5078 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20110085978.pdf [firstpage_image] =>[orig_patent_app_number] => 12922368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458749 [patent_doc_number] => 20090258901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'LIGANDS FOR MONOAMINE RECEPTORS AND TRANSPORTERS, AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/403311 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 76086 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258901.pdf [firstpage_image] =>[orig_patent_app_number] => 12403311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740635 [patent_doc_number] => 08106042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => '1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors' [patent_app_type] => utility [patent_app_number] => 12/921922 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6161 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106042.pdf [firstpage_image] =>[orig_patent_app_number] => 12921922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254865 [patent_doc_number] => 08618282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Process for preparing benzothiazepines from gamma-aminoalkylbenzenes' [patent_app_type] => utility [patent_app_number] => 12/397212 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13854 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12397212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580883 [patent_doc_number] => 20110294766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => '16 Alpha, 17 Alpha-Acetal Glucocorticosteroidal Derivatives and their Use' [patent_app_type] => utility [patent_app_number] => 12/919160 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24856 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294766.pdf [firstpage_image] =>[orig_patent_app_number] => 12919160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501630 [patent_doc_number] => 20090162318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/392620 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41522 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162318.pdf [firstpage_image] =>[orig_patent_app_number] => 12392620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404526 [patent_doc_number] => 20090239840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/370560 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33678 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239840.pdf [firstpage_image] =>[orig_patent_app_number] => 12370560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6549927 [patent_doc_number] => 20100016581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'METHODS OF PREPARING POLYMORPHIC FORM A OF BAZEDOXIFENE ACETATE' [patent_app_type] => utility [patent_app_number] => 12/369104 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5980 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016581.pdf [firstpage_image] =>[orig_patent_app_number] => 12369104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028335 [patent_doc_number] => 08143243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Compounds for the treatment of hepatitis C' [patent_app_type] => utility [patent_app_number] => 12/369222 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 108532 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2402 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143243.pdf [firstpage_image] =>[orig_patent_app_number] => 12369222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6549943 [patent_doc_number] => 20100016582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'METHODS OF CONVERTING POLYMORPHIC FORM B OF BAZEDOXIFENE ACETATE TO POLYMORPHIC FORM A OF BAZEDOXIFENE ACETATE' [patent_app_type] => utility [patent_app_number] => 12/369315 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5206 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016582.pdf [firstpage_image] =>[orig_patent_app_number] => 12369315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545181 [patent_doc_number] => 20100016290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'AMORPHOUS POLYMORPH OF BAZEDOXIFENE ACETATE' [patent_app_type] => utility [patent_app_number] => 12/369383 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4951 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016290.pdf [firstpage_image] =>[orig_patent_app_number] => 12369383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626579 [patent_doc_number] => 08796260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Imidazobenzazepine CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/867332 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11886 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12867332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564706 [patent_doc_number] => 20090137559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'BAZEDOXIFENE ASCORBATE' [patent_app_type] => utility [patent_app_number] => 12/363906 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5894 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137559.pdf [firstpage_image] =>[orig_patent_app_number] => 12363906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003724 [patent_doc_number] => 20110118460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'PROCESS FOR THE SYNTHESIS OF QUETIAPINE' [patent_app_type] => utility [patent_app_number] => 13/001713 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1649 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118460.pdf [firstpage_image] =>[orig_patent_app_number] => 13001713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811461 [patent_doc_number] => 08133992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Azepinoindole and pyridoindole derivatives as pharmaceutical agents' [patent_app_type] => utility [patent_app_number] => 12/362269 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77014 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133992.pdf [firstpage_image] =>[orig_patent_app_number] => 12362269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639786 [patent_doc_number] => 20100174065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/360886 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38652 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0174/20100174065.pdf [firstpage_image] =>[orig_patent_app_number] => 12360886 [rel_patent_id] =>[rel_patent_doc_number] =>)